BELLUS Health Financials
BLUDelisted Stock | USD 14.74 0.00 0.00% |
With this module, you can analyze BELLUS financials for your investing period. You should be able to track the changes in BELLUS Health individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
BELLUS |
Understanding current and past BELLUS Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BELLUS Health's financial statements are interrelated, with each one affecting the others. For example, an increase in BELLUS Health's assets may result in an increase in income on the income statement.
Evaluating BELLUS Health's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of BELLUS Health's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the BELLUS Health's relative financial performance
Chance Of Distress
Over 100
100 | Zero |
Dangerous
BELLUS Health has more than 100 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for BELLUS Health stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, BELLUS Health's odds of distress score SHOULD NOT be confused with the real chance of BELLUS Health filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as BELLUS is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include BELLUS Health's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More InfoThe data published in BELLUS Health's official financial statements usually reflect BELLUS Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of BELLUS Health. For example, before you start analyzing numbers published by BELLUS accountants, it's critical to develop an understanding of what BELLUS Health's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of BELLUS Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BELLUS Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in BELLUS Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BELLUS Health. Please utilize our Beneish M Score to check the likelihood of BELLUS Health's management manipulating its earnings.
BELLUS Health Company Summary
BELLUS Health competes with Marfrig Global, Hawaiian Holdings, SunOpta, Alaska Air, and United Airlines. BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | CA07987C2040 |
Business Address | 275 Armand-Frappier Boulevard, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | NYSE Composite |
Website | www.bellushealth.com |
Phone | 450 680 4500 |
Currency | USD - US Dollar |
You should never invest in BELLUS Health without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of BELLUS Stock, because this is throwing your money away. Analyzing the key information contained in BELLUS Health's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
BELLUS Health Key Financial Ratios
Generally speaking, BELLUS Health's financial ratios allow both analysts and investors to convert raw data from BELLUS Health's financial statements into concise, actionable information that can be used to evaluate the performance of BELLUS Health over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BELLUS Health reports annually and quarterly.Return On Equity | -0.27 | |||
Return On Asset | -0.17 | |||
Target Price | 16.05 |
BELLUS Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BELLUS Health's current stock value. Our valuation model uses many indicators to compare BELLUS Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BELLUS Health competition to find correlations between indicators driving BELLUS Health's intrinsic value. More Info.BELLUS Health is number one stock in market capitalization category among related companies. It is number one stock in shares owned by insiders category among related companies . The ratio of Market Capitalization to Shares Owned By Insiders for BELLUS Health is about 182,166,342 . Comparative valuation analysis is a catch-all model that can be used if you cannot value BELLUS Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BELLUS Health's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BELLUS Health's earnings, one of the primary drivers of an investment's value.BELLUS Health Market Pulse
Quote | 14.74 |
Change(%) | 0.00 |
Change | 0.00 |
Open | 14.74 |
Low | 14.74 |
High | 14.74 |
Volume | 0 |
Exchange | NASDAQ |
About BELLUS Health Financials
What exactly are BELLUS Health Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include BELLUS Health's income statement, its balance sheet, and the statement of cash flows. Potential BELLUS Health investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although BELLUS Health investors may use each financial statement separately, they are all related. The changes in BELLUS Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BELLUS Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze BELLUS Health Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as BELLUS Health is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of BELLUS has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if BELLUS Health's financials are consistent with your investment objective using the following steps:- Review BELLUS Health's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand BELLUS Health's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare BELLUS Health's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if BELLUS Health's stock is overvalued or undervalued.
BELLUS Health March 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of BELLUS Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BELLUS Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of BELLUS Health based on widely used predictive technical indicators. In general, we focus on analyzing BELLUS Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BELLUS Health's daily price indicators and compare them against related drivers.
Downside Deviation | 1.54 | |||
Information Ratio | 0.1164 | |||
Maximum Drawdown | 99.31 | |||
Value At Risk | (1.37) | |||
Potential Upside | 2.83 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in BELLUS Stock
If you are still planning to invest in BELLUS Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BELLUS Health's history and understand the potential risks before investing.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |